This profile has not been claimed and data may not be accurate.
14th percentile
81st percentile
Founder and CIO of Glade Brook Capital Partners, former Sanofi CEO
Credibility
Experience · 83th percentile
- Approximately 14 years of investing experience based on Glade Brook Capital's founding around 2011.
Relationship Matrix
Founder score
- 95%Probability of being accurate (95%)Wikipedia page exists for Paul Hudson (businessman), confirming public notability.
- 72%Probability of being accurate (72%)Current founder and CIO of Glade Brook Capital Partners.
Investor score
- 95%Probability of being accurate (95%)Active GP and fund manager at Glade Brook Capital Partners, confirmed by SEC Form D filings for multiple pooled investment funds.
- 80%Probability of being accurate (80%)Partner and CIO at Glade Brook Capital Partners, a recognized investment firm with multiple active funds.
- 50%Probability of being accurate (50%)Approximately 14 years of investing experience based on Glade Brook Capital's founding around 2011.
What you likely need
You'd get the most out of Festival events that put you in a room with late-stage biotech and digital health founders who need a board member with real regulatory and commercial weight behind them. Roundtables with other healthcare-focused fund managers would help you pressure-test and sharpen the Glade Brook investment thesis before you publish it publicly. And smaller, off-the-record dinners with fellow ex-Big Pharma executives now deploying capital would give you the peer accountability to pace yourself intentionally as you define this next chapter.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- fundraisingA healthcare investor roundtable with other founder-turned-fund-managers to pressure-test and sharpen the Glade Brook Capital Partners investment thesis before you publish it as a public portfolio page
- introsA Sanofi, Novartis, and AstraZeneca alumni dinner to surface proprietary biotech and digital health deal flow from executives who know your operating credibility firsthand
- tacticalA late-stage biotech and digital health founder roundtable for founders actively seeking board members with FDA regulatory, global commercial, and Big Pharma partnership experience
- positioningA Fortune and LinkedIn healthcare-AI thought leadership dinner with other high-engagement operator-investors publishing on AI in drug discovery and digital health to cross-amplify reach and sharpen your public positioning
- introsA dinner for former Fortune 500 pharma and biotech CEOs now managing their own investment vehicles, to share deal sourcing strategies and co-investment opportunities in healthcare and AI
- fundraisingA Glade Brook-hosted office hours session with 4-6 Series B and C digital health founders who need a capital partner with hands-on global market and regulatory experience, not just a check
- tacticalA tactical workshop for emerging healthcare fund managers on optimizing Crunchbase and PitchBook profiles to improve discoverability with founders and institutional co-investors
- wellbeingAn intimate off-the-record dinner for executives who recently stepped out of large-company CEO roles into investing, to share honest frameworks for structuring time and avoiding over-commitment before an investment strategy is fully defined